Citadel Advisors - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is and the CUSIP is 405024900. A total of 1 filers reported holding HAEMONETICS CORP in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q2 2015$165,000
+161.9%
4,000
+185.7%
0.00%
Q1 2015$63,000
+472.7%
1,400
+366.7%
0.00%
Q4 2014$11,0003000.00%
Other shareholders
HAEMONETICS CORP shareholders Q2 2015
NameSharesValueWeighting ↓
JPMORGAN CHASE & CO 35,900$4,263,0000.00%
GROUP ONE TRADING, L.P. 3,900$463,0000.00%
SIMPLEX TRADING, LLC 1$11,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of HAEMONETICS CORP shareholders